Medtronic (MDT)

Let's look beyond recent obstacles these companies have encountered.

Cardiovascular and surgical segments drove 13.7% organic revenue growth.

Analyst ratings and news for high-yield healthcare stocks Medtronic (3.06%), Smith & Nephew (2.74%) and GSK (3.65%).

Intuitive Surgical's flywheel isn't selling new surgical robots, its selling parts and services to support the ones it has already sold.

Industry Key HighlightsThe Saudi Arabia IoMT Market is expected to increase from USD 289.34 million in 2025 to USD 676.63 million by 2031.The market is pro

The medical device maker is on the cusp of a multi-year recovery.

A solid moat favors revenue growth, and that's good news for investors.

MDT shares rise after Q1 beat and raised FY27 growth guidance. Analysts maintain Buy/Outperform ratings, citing broad-based strength.

Medtronic (NYSE:MDT) reported better-than-expected results and raised its FY27 EPS guidance. Analysts are bullish with raised price targets.

Medtronic beat Q1 FY2027 estimates, raised guidance, and holds a Moderate Buy rating from analysts, with its 3%-plus dividend positioning it near Dividend King status.

MiniMed Group (NASDAQ:MMED) reported fiscal 2027 first-quarter revenue of $843 million, with organic revenue growth of 15.8%, as demand for its newer insulin-delivery and continuous glucose monitoring products supported growth in the United States and international markets. Chief Executive Officer

Medtronic (NYSE:MDT) reported fiscal 2027 first-quarter revenue of $9.8 billion and adjusted earnings per share of $1.45, as the medical-device maker cited broad-based demand, commercial execution and momentum in several growth platforms. Revenue increased 13.7% on both a reported and organic basis

Medtronic (NYSE: MDT) stock rose after beating Q1 estimates and raising its FY27 forecast on strong cardiovascular sales.

Shares of both advanced on their lifted full-year guidance.

U.S. stocks traded lower this morning, with the Dow Jones index falling more than 300 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.58% to 52,876.43 while the NASDAQ dipped 1.40% to

With U.S. stock futures trading slightly lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

Medtronic plc (NYSE:MDT) to release Q1 earnings on Sept. 1. Analysts expect $1.39/share, revenue of $9.54B. Dividend yield at 3.16%. Stock closed at $91.23 on Friday.

Medtronic plc (NYSE: MDT) will release Q1 earnings on Sept. 1. Analysts predict $1.39 EPS and $9.54B revenue. Stock fell 2.2% to $89.97 on Aug. 27.

The maternal health market is characterized by rapid technological advancements and increasing demand for improved prenatal and postnatal care solutions gl

On Aug. 26, 2026, a cyberattack halted order processing and shipping at the medical device maker, leaving investors uncertain about the speed of recovery and near-term shipment delays.

Investors appear to be second-guessing the company's long-term growth prospects in light of its recent earnings numbers.

The space company is popular right now, but these other corporations look more attractive.